Works matching IS 2162-4011 AND VI 2 AND IP 3 AND DT 2013

Results: 32

Novel multifunctional antibody approved for the treatment of breast cancer.

Published in:

2013

By:

Mavilio, Domenico;
Galluzzi, Lorenzo;
Lugli, Enrico

Publication type:

Editorial

Trial watch: Chemotherapy with immunogenic cell death inducers.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23510-1, doi. 10.4161/onci.23510

By:

Vacchelli, Erika;
Senovilla, Laura;
Eggermont, Alexander;
Fridman, Wolf Hervé;
Galon, Jérôme;
Zitvogel, Laurence;
Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Naturally circulating dendritic cells to vaccinate cancer patients.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23431-1, doi. 10.4161/onci.23431

By:

Bol, Kalijn F.;
Tel, Jurjen;
De Vries, I. Jolanda M.;
Figdor, Carl G.

Publication type:

Article

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23430-1, doi. 10.4161/onci.23430

By:

Dosset, Magalie;
Vauchy, Charline;
Beziaud, Laurent;
Adotevi, Olivier;
Godet, Yann

Publication type:

Article

A road less traveled paved by IDO silencing.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23322-1, doi. 10.4161/onci.23322

By:

Manuel, Edwin R.;
Diamond, Don J.

Publication type:

Article

A new strategy to target regulatory T cells in solid tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. 1, doi. 10.4161/onci.23338

By:

Thomas-Schoemann, Audrey;
Batteux, Frédéric;
Alexandre, Jérôme

Publication type:

Article

MIF: Metastasis/MDSC-inducing factor?

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23337-1, doi. 10.4161/onci.23337

By:

Simpson, Kendra D.;
Cross, Janet V.

Publication type:

Article

Non-classical MHC Class I molecules regulating natural killer cell function.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23336-1, doi. 10.4161/onci.23336

By:

Smyth, Mark J.;
Sullivan, Lucy C.;
Brooks, Andrew G.;
Andrews, Daniel M.

Publication type:

Article

Early in vivo signaling profiles in MUC1-specific CD4+ T cells responding to two different MUC1-targeting vaccines in two different microenvironments.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23429-1, doi. 10.4161/onci.23429

By:

Reichenbach, Dawn K.;
Finn, Olivera J.

Publication type:

Article

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23187-1, doi. 10.4161/onci.23187

By:

Su Yin Lim;
Gordon-Weeks, Alex N.;
Lei Zhao;
Tapmeier, Thomas T.;
Jae Hong Im;
Yunhong Cao;
Beech, John;
Allen, Danny;
Smart, Sean;
Muschel, Ruth J.

Publication type:

Article

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23472-1, doi. 10.4161/onci.23472

By:

Prada, Nicole;
Antoni, Guillemette;
Commo, Frédéric;
Rusakiewicz, Sylvie;
Semeraro, Michaela;
Boufassa, Faroudy;
Lambotte, Olivier;
Meyer, Laurence;
Gougeon, Marie-Lise;
Zitvogel, Laurence

Publication type:

Article

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23304-1, doi. 10.4161/onci.23304

By:

Kabelitz, Dieter;
Kalyan, Shirin;
Oberg, Hans-Heinrich;
Wesch, Daniela

Publication type:

Article

Targeting two co-operating cytokines efficiently shapes immune responses.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23205-1, doi. 10.4161/onci.23205

By:

Hombach, Andreas A.;
Abken, Hinrich

Publication type:

Article

HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23249-1, doi. 10.4161/onci.23249

By:

Qing-Wen Xu;
Yu Zhang;
Xiao-Song Wang

Publication type:

Article

IL-10 control of dendritic cells in the skin.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23186-1, doi. 10.4161/onci.23186

By:

Clausen, Björn E.;
Girard-Madoux, Mathilde J.H.

Publication type:

Article

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+ T cells by plasmacytoid dendritic cells.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23185-1, doi. 10.4161/onci.23185

By:

Faget, Julien;
Sisirak, Vanja;
Blay, Jean-Yves;
Caux, Christophe;
Bendriss-Vermare, Nathalie;
Ménétrier-Caux, Christine

Publication type:

Article

Bacteria evade immune recognition via TLR13 and binding of their 23S rRNA by MLS antibiotics by the same mechanisms.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23141-1, doi. 10.4161/onci.23141

By:

Hochrein, Hubertus;
Kirschning, Carsten J.

Publication type:

Article

Identification of human tissue cross-presenting dendritic cells.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23140-1, doi. 10.4161/onci.23140

By:

Haniffa, Muzlifah;
Collin, Matthew;
Ginhoux, Florent

Publication type:

Article

COX2 regulation of breast cancer bone metastasis.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23129-1, doi. 10.4161/onci.23129

By:

Karavitis, John;
Ming Zhang

Publication type:

Article

DEC-205 is a cell surface receptor for CpG oligonucleotides.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23128-1, doi. 10.4161/onci.23128

By:

Caminschi, Irina;
Meuter, Simone;
Heath, William R.

Publication type:

Article

Utilizing TH9 cells as a novel therapeutic strategy for malignancies.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23084-1, doi. 10.4161/onci.23084

By:

Yong Lu;
Qing Yi

Publication type:

Article

TGFβ1 microenvironment determines dendritic cell development.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23083-1, doi. 10.4161/onci.23083

By:

Seré, Kristin;
Felker, Piritta;
Hieronymus, Thomas;
Zenke, Martin

Publication type:

Article

Regulation of DC development and DC-mediated T-cell immunity via CISH.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23404-1, doi. 10.4161/onci.23404

By:

Mohammad Alam Miah;
Bae, Yong-Soo

Publication type:

Article

Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23127-1, doi. 10.4161/onci.23127

By:

Demaria, Sandra;
Pilones, Karsten A.;
Formenti, Silvia C.;
Dustin, Michael L.

Publication type:

Article

Immune effects of 5-fluorouracil.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23139-1, doi. 10.4161/onci.23139

By:

Ghiringhelli, Francois;
Bruchard, Melanie;
Apetoh, Lionel

Publication type:

Article

Unique pulmonary antigen presentation may call for an alternative approach toward lung cancer immunotherapy.

Published in:

2013

By:

Stephanie Chang;
Xue Lin;
Higashikubo, Ryuji;
Toth, Kelsey;
Gelman, Andrew E.;
Kreisel, Daniel;
Krupnick, Alexander S.

Publication type:

Opinion

The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23618-1, doi. 10.4161/onci.23618

By:

Carlson, Lena-Maria;
De Geer, Anna;
Sveinbjørnsson, Baldur;
Orrego, Abiel;
Martinsson, Tommy;
Kogner, Per;
Levitskaya, Jelena

Publication type:

Article

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23562-1, doi. 10.4161/onci.23562

By:

Dannenmann, Stefanie Regine;
Thielicke, Julia;
Stöckli, Martina;
Matter, Claudia;
Von Boehmer, Lotta;
Cecconi, Virginia;
Hermanns, Thomas;
Hefermehl, Lukas;
Schraml, Peter;
Moch, Holger;
Knuth, Alexander;
Van den Broek, Maries

Publication type:

Article

Cancer vaccines.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23403-1, doi. 10.4161/onci.23403

By:

Yaddanapudi, Kavitha;
Mitchell, Robert A.;
Eaton, John W.

Publication type:

Article

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23402-1, doi. 10.4161/onci.23402

By:

Modak, Shakeel;
Kushner, Brian H.;
Kramer, Kim;
Vickers, Andrew;
Irene Y. Cheung;
Nai-Kong V. Cheung

Publication type:

Article

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23428-1, doi. 10.4161/onci.23428

By:

Creelan, Ben C.;
Antonia, Scott;
Bepler, Gerold;
Garrett, Timothy J.;
Simon, George R.;
Soliman, Hatem H.

Publication type:

Article

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23401-1, doi. 10.4161/onci.23401

By:

Pellegatta, Serena;
Eoli, Marica;
Frigerio, Simona;
Antozzi, Carlo;
Bruzzone, Maria Grazia;
Cantini, Gabriele;
Nava, Sara;
Anghileri, Elena;
Cuppini, Lucia;
Cuccarini, Valeria;
Ciusani, Emilio;
Dossena, Marta;
Pollo, Bianca;
Mantegazza, Renato;
Parati, Eugenio A.;
Finocchiaro, Gaetano

Publication type:

Article

Works matching IS 2162-4011 AND VI 2 AND IP 3 AND DT 2013

Novel multifunctional antibody approved for the treatment of breast cancer.

Trial watch: Chemotherapy with immunogenic cell death inducers.

Naturally circulating dendritic cells to vaccinate cancer patients.

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination.

A road less traveled paved by IDO silencing.

A new strategy to target regulatory T cells in solid tumors.

MIF: Metastasis/MDSC-inducing factor?

Non-classical MHC Class I molecules regulating natural killer cell function.

Early in vivo signaling profiles in MUC1-specific CD4<sup>+</sup> T cells responding to two different MUC1-targeting vaccines in two different microenvironments.

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis.

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.

Targeting two co-operating cytokines efficiently shapes immune responses.

HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens.

IL-10 control of dendritic cells in the skin.

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4<sup>+</sup> T cells by plasmacytoid dendritic cells.

Bacteria evade immune recognition via TLR13 and binding of their 23S rRNA by MLS antibiotics by the same mechanisms.

Identification of human tissue cross-presenting dendritic cells.

COX2 regulation of breast cancer bone metastasis.

DEC-205 is a cell surface receptor for CpG oligonucleotides.

Utilizing T<sub>H</sub>9 cells as a novel therapeutic strategy for malignancies.

TGFβ1 microenvironment determines dendritic cell development.

Regulation of DC development and DC-mediated T-cell immunity via CISH.

Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment.

Immune effects of 5-fluorouracil.

Unique pulmonary antigen presentation may call for an alternative approach toward lung cancer immunotherapy.

The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes.

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.

Cancer vaccines.

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan.

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer.

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.